Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome.

Ferré N, Feliu A, García-Heredia A, Marsillach J, París N, Zaragoza-Jordana M, Mackness B, Mackness M, Escribano J, Closa-Monasterolo R, Joven J, Camps J.

Clin Biochem. 2013 Dec;46(18):1830-6. doi: 10.1016/j.clinbiochem.2013.08.020. Epub 2013 Sep 10.

PMID:
24028901
2.

Relationship of serum resistin level to traits of metabolic syndrome and serum paraoxonase 1 activity in a population with a broad range of body mass index.

Bajnok L, Seres I, Varga Z, Jeges S, Peti A, Karanyi Z, Juhasz A, Csongradi E, Mezosi E, Nagy EV, Paragh G.

Exp Clin Endocrinol Diabetes. 2008 Nov;116(10):592-9. doi: 10.1055/s-2008-1065350. Epub 2008 May 9.

PMID:
18465683
3.

Paraoxonase 1 activities and genetic variation in childhood obesity.

Rupérez AI, López-Guarnido O, Gil F, Olza J, Gil-Campos M, Leis R, Tojo R, Cañete R, Gil A, Aguilera CM.

Br J Nutr. 2013 Nov 14;110(9):1639-47. doi: 10.1017/S0007114513001967. Epub 2013 Jun 21.

PMID:
23789921
4.

Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.

Bajnok L, Seres I, Varga Z, Jeges S, Peti A, Karanyi Z, Juhasz A, Csongradi E, Mezosi E, Nagy EV, Paragh G.

Metabolism. 2007 Nov;56(11):1542-9.

PMID:
17950106
6.

Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents.

Torun E, Gökçe S, Ozgen İT, Aydın S, Cesur Y.

J Pediatr Endocrinol Metab. 2014 Jul;27(7-8):667-75. doi: 10.1515/jpem-2013-0337.

PMID:
24706428
7.

Positive correlation of paraoxonase 1 (PON1) activity with serum insulin level and HOMA-IR in dementia. A possible advantageous role of PON1 in dementia development.

Bednarska-Makaruk M, Graban A, Lipczyńska-Łojkowska W, Bochyńska A, Rodo M, Krzywkowski T, Ryglewicz D, Wehr H.

J Neurol Sci. 2013 Jan 15;324(1-2):172-5. doi: 10.1016/j.jns.2012.11.003. Epub 2012 Nov 22.

PMID:
23182497
8.

Serum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndrome.

Eren E, Abuhandan M, Solmaz A, Taşkın A.

J Clin Res Pediatr Endocrinol. 2014 Sep;6(3):163-8. doi: 10.4274/Jcrpe.1454.

9.

Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels.

Koncsos P, Seres I, Harangi M, Illyés I, Józsa L, Gönczi F, Bajnok L, Paragh G.

Pediatr Res. 2010 Mar;67(3):309-13. doi: 10.1203/PDR.0b013e3181c9fb66.

PMID:
19915520
10.
11.

Longitudinal association between IGFBP-1 levels and parameters of the metabolic syndrome in obese children before and after weight loss.

Reinehr T, Kleber M, Toschke AM, Woelfle J, Roth CL.

Int J Pediatr Obes. 2011 Aug;6(3-4):236-43. doi: 10.3109/17477166.2010.544739. Epub 2011 Jan 3.

PMID:
21198359
12.

The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.

Quijada Z, Paoli M, Zerpa Y, Camacho N, Cichetti R, Villarroel V, Arata-Bellabarba G, Lanes R.

Pediatr Diabetes. 2008 Oct;9(5):464-71. doi: 10.1111/j.1399-5448.2008.00406.x. Epub 2008 May 23.

PMID:
18507788
13.

Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.

Yamada A, Shoji T, Tahara H, Emoto M, Nishizawa Y.

Metabolism. 2001 Jul;50(7):805-11.

PMID:
11436186
14.

Persistent elevation of paraoxonase-1 specific enzyme activity after weight reduction in obese non-diabetic men with metabolic syndrome.

Liang KW, Lee WJ, Lee IT, Lee WL, Lin SY, Hsu SL, Wan CJ, Yu CY, Tsai IC, Fu CP, Ting CT, Sheu WH.

Clin Chim Acta. 2011 Sep 18;412(19-20):1835-41. doi: 10.1016/j.cca.2011.06.018. Epub 2011 Jun 17.

PMID:
21704607
15.

Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.

Kappelle PJ, Bijzet J, Hazenberg BP, Dullaart RP.

Arch Med Res. 2011 Apr;42(3):219-25. doi: 10.1016/j.arcmed.2011.05.002.

PMID:
21722818
16.

Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress.

Krzystek-Korpacka M, Patryn E, Hotowy K, Czapińska E, Majda J, Kustrzeba-Wójcicka I, Noczyńska A, Gamian A.

Adv Clin Exp Med. 2013 Mar-Apr;22(2):229-36.

17.

High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.

Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA.

Clin Endocrinol (Oxf). 2009 Feb;70(2):221-6. doi: 10.1111/j.1365-2265.2008.03306.x.

PMID:
18505467
18.

Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity.

Bortolasci CC, Vargas HO, Souza-Nogueira A, Gastaldello Moreira E, Vargas Nunes SO, Berk M, Dodd S, Barbosa DS, Maes M.

Redox Rep. 2014 Nov;19(6):232-41. doi: 10.1179/1351000214Y.0000000093. Epub 2014 Jul 18.

PMID:
25037113
19.

[Cardiovascular risk and metabolic profile in obese children and adolescents with low insulin sensitivity].

Burrows R, Burgueño M, Leiva L, Ceballos X, Guillier I, Gattas V, Lera L, Albala C.

Rev Med Chil. 2005 Jul;133(7):795-804. Epub 2005 Aug 26. Spanish.

20.

Metabolic syndrome in children with chronic kidney disease: PON1 and treatment modality.

Gómez-Díaz RA, García-Bello JA, Mondragón-González R, Díaz-Flores M, Valladares-Salgado A, Gallardo JM, Talavera JO, Wacher NH.

Arch Med Res. 2013 Nov;44(8):645-9. doi: 10.1016/j.arcmed.2013.10.014. Epub 2013 Nov 8.

PMID:
24211756

Supplemental Content

Support Center